Core Viewpoint - Yuan Tian Biological has successfully completed a pre-A++ round financing of several tens of millions, which will be primarily used for the construction of a 5,000-ton production line and the planning of a 100,000-ton production line, accelerating the large-scale production of bio-enzyme regenerated materials [1] Group 1: Capital Investment - The investment from Tian Chuang Capital reflects strong market confidence, as Yuan Tian Biological is the first company in China to commercialize bio-regeneration technology [2] - Since August of last year, Yuan Tian Biological has completed three rounds of financing, indicating the unique value and development potential of its technology route [2] - Each financing round has been aligned with the company's different development stages, providing continuous momentum for its scale expansion [2] Group 2: Technological Advancements - Yuan Tian Biological's self-developed PET degrading enzyme YTZYME™ has significantly improved the degradation efficiency of waste PET from "300 years" to "8 hours," addressing the challenges of recycling blended fabrics [4] - The company is expanding its plastic recycling technology matrix from PET to PA6, providing innovative solutions for the recycling of PA6 materials [5][6] - Recent advancements in PA6 bio-recycling have established new technical pathways for sustainable use in various industries, including textiles, automotive, and electronics [6] Group 3: Industry Leadership - Yuan Tian Biological has achieved several breakthroughs in technological innovation and commercial transformation, including winning first place in a national innovation and entrepreneurship competition [7] - The company has received the world's first bio-regeneration GRS certification, setting a new technical standard and certification paradigm for the industry [7] - A strategic partnership with Tiandai Environmental has been established to address the recycling bottlenecks of post-consumer waste textiles, creating a complete closed-loop from recycling to regeneration [7] Group 4: Future Plans - Following this round of financing, Yuan Tian Biological will accelerate the construction of the 5,000-ton and 100,000-ton production lines, enhancing production capacity and product competitiveness [8] - The company will also increase market promotion efforts to expand downstream application scenarios, driving the large-scale application of bio-enzyme regenerated materials across more industries [8]

Core Viewpoint - Yuan Tian Biotechnology has successfully completed a pre-A++ round financing of several tens of millions, which will be used for the construction of a 5,000-ton production line and the planning of a 100,000-ton production line, aiming to accelerate the large-scale production of bio-enzyme regenerated materials [2]. Group 1: Financing and Investment - Yuan Tian Biotechnology has completed three rounds of financing within a year, with investments from various notable institutions, indicating the unique value and development potential of its technology [3]. - The latest financing round was exclusively led by Tian Chuang Capital, which aims to support the company's capacity expansion and new product development in the green materials sector [5]. Group 2: Technological Advancements - The company has developed the PET degrading enzyme YTZYME™, which enhances the degradation efficiency of waste PET from "300 years in nature" to "8 hours in industrial conditions," addressing challenges in recycling blended fabrics [5]. - Yuan Tian Biotechnology is expanding its recycling technology matrix from PET to PA6, providing innovative solutions for the sustainable use of PA6 materials in various industries [6][8]. Group 3: Market Potential and Strategy - The market for recycled bio-based PET (rbPET) is significant and essential, with Yuan Tian's bio-enzyme method offering broad raw material adaptability, high recovery rates, and cost advantages, positioning the company as a potential leader in the global green circular materials field [5]. - Following the recent financing, the company plans to accelerate the construction of its production lines and enhance market promotion efforts to expand the application of bio-enzyme regenerated materials across more industries [8].